Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule

Area of Science:

• Virology
• Immunology
• Public Health

Background:

• Tick-borne encephalitis (TBE) is a serious neurological disease caused by a Flavivirus.
• Current treatment for TBE is symptomatic, highlighting the importance of prevention through vaccination.
• Optimizing TBE vaccination schedules is crucial for effective disease prevention.

Purpose of the Study:

• To compare the immunogenicity of four different TBE vaccination schedules.
• To identify the most effective TBE vaccine schedule for rapid and sustained protection.
• To provide data on immune response using ELISA and neutralization tests.

Main Methods:

• A randomized controlled trial involving 398 healthy subjects aged 12 years and older.
• Four vaccination groups: rapid (days 0, 7, 21), conventional (days 0, 28, 300), modified conventional (days 0, 21, 300), and accelerated conventional (days 0, 14, 300).
• Immune response assessed via ELISA and neutralization tests (NT) at various time points.

Main Results:

• Higher antibody levels by day 21 were observed in the rapid and accelerated conventional schedules.
• The rapid and conventional schedules demonstrated higher antibody titers on days 42, 180, and 300 compared to the accelerated and modified conventional schedules.
• The rapid schedule achieved both fast protection and high antibody titers throughout the 300-day observation period.

Conclusions:

• The rapid TBE vaccination schedule (days 0, 7, 21) is superior in providing early and sustained immune protection.
• This study supports the rapid schedule as an effective strategy for TBE prevention.
• Optimized TBE vaccine schedules enhance public health outcomes by improving disease prevention.